BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33769184)

  • 21. Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases.
    Zhu Y; Wang H; Guo Y; Cao J; Li H
    Mini Rev Med Chem; 2023; 23(19):1893-1904. PubMed ID: 37055897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico anti-alzheimer study of phytochemicals from Lamiaceae family through GSK3-β inhibition.
    Zareei S; Pourmand S; Eskandarzadeh M; Massahi S
    Sci Rep; 2024 Jan; 14(1):834. PubMed ID: 38191548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
    Schütz SV; Cronauer MV; Rinnab L
    J Cell Biochem; 2010 Apr; 109(6):1192-200. PubMed ID: 20127713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo.
    Tapia-Rojas C; Schüller A; Lindsay CB; Ureta RC; Mejías-Reyes C; Hancke J; Melo F; Inestrosa NC
    Biochem J; 2015 Mar; 466(2):415-30. PubMed ID: 25423492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity.
    Arfeen M; Patel R; Khan T; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(12):2578-93. PubMed ID: 26209183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of kinase inactivation and nonbinding of FRATide to GSK3β due to K85M mutation: molecular dynamics simulation and normal mode analysis.
    Lu S; Jiang Y; Lv J; Zou J; Wu T
    Biopolymers; 2011 Oct; 95(10):669-81. PubMed ID: 21442609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Gao Y; Zhang P; Cui A; Ye DY; Xiang M; Chu Y
    Bioorg Med Chem; 2018 Nov; 26(20):5479-5493. PubMed ID: 30293796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying Potential Ligand Binding Sites on Glycogen Synthase Kinase 3 Using Atomistic Cosolvent Simulations.
    DasGupta D; Mehrani R; Carlson HA; Sharma S
    ACS Appl Bio Mater; 2024 Feb; 7(2):588-595. PubMed ID: 37141501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for the complete loss of GSK3beta catalytic activity due to R96 mutation investigated by molecular dynamics study.
    Zhang N; Jiang Y; Zou J; Yu Q; Zhao W
    Proteins; 2009 May; 75(3):671-81. PubMed ID: 19003984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyanidin-3-glucoside reverses ethanol-induced inhibition of neurite outgrowth: role of glycogen synthase kinase 3 Beta.
    Chen G; Bower KA; Xu M; Ding M; Shi X; Ke ZJ; Luo J
    Neurotox Res; 2009 May; 15(4):321-31. PubMed ID: 19384566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells.
    Wang L; Lin HK; Hu YC; Xie S; Yang L; Chang C
    J Biol Chem; 2004 Jul; 279(31):32444-52. PubMed ID: 15178691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
    Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.
    Wagner FF; Benajiba L; Campbell AJ; Weïwer M; Sacher JR; Gale JP; Ross L; Puissant A; Alexe G; Conway A; Back M; Pikman Y; Galinsky I; DeAngelo DJ; Stone RM; Kaya T; Shi X; Robers MB; Machleidt T; Wilkinson J; Hermine O; Kung A; Stein AJ; Lakshminarasimhan D; Hemann MT; Scolnick E; Zhang YL; Pan JQ; Stegmaier K; Holson EB
    Sci Transl Med; 2018 Mar; 10(431):. PubMed ID: 29515000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
    Pardo M; Abrial E; Jope RS; Beurel E
    Genes Brain Behav; 2016 Mar; 15(3):348-55. PubMed ID: 26749572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
    Li X; Wang X; Tian Z; Zhao H; Liang D; Li W; Qiu Y; Lu S
    J Mol Model; 2014 Sep; 20(9):2407. PubMed ID: 25142337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway.
    Zhu H; Han B; Pan X; Qi H; Xu L
    J Clin Pharm Ther; 2012 Feb; 37(1):65-70. PubMed ID: 21410737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.
    Neary JT; Kang Y
    J Neurosci Res; 2006 Aug; 84(3):515-24. PubMed ID: 16810687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycogen synthase kinase 3β inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling.
    Pyko IV; Nakada M; Sabit H; Teng L; Furuyama N; Hayashi Y; Kawakami K; Minamoto T; Fedulau AS; Hamada J
    Carcinogenesis; 2013 Oct; 34(10):2206-17. PubMed ID: 23715499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Glycogen Synthase Kinase-3β by Phosphorylation and O-β-Linked N-Acetylglucosaminylation: Implications on Tau Protein Phosphorylation.
    El Hajjar L; Page A; Bridot C; Cantrelle FX; Landrieu I; Smet-Nocca C
    Biochemistry; 2024 May; ():. PubMed ID: 38788673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unraveling the role of Arg4 and Arg6 in the auto-inhibition mechanism of GSK3β from molecular dynamics simulation.
    Mou L; Li M; Lu SY; Li S; Shen Q; Zhang J; Li C; Lu X
    Chem Biol Drug Des; 2014 Jun; 83(6):721-30. PubMed ID: 24444018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.